Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Gastrointestinal 2 Thoracic 1

Conditions

Recurrence 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 159 Carboplatin 147 Cisplatin 130 Pemetrexed 103 Paclitaxel 89 Nivolumab 71 Radiotherapy 69 Docetaxel 62 Erlotinib Hydrochloride 58 Gemcitabine 57 Etoposide 44 osimertinib 43 Bevacizumab 43 Cyclophosphamide 42 durvalumab 41 atezolizumab 35 Cetuximab 33 Radiosurgery 26 130-nm albumin-bound paclitaxel 26 fludarabine 23 Ipilimumab 23 Radiation 21 Magnetic Resonance Spectroscopy 21 Irinotecan 21 Taxes 20 Oxaliplatin 20 Fluorouracil 20 Gefitinib 19 Everolimus 19 Topotecan 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × PEGPH20 × Thoracic × Clear all

NCT02346370 2019-02-08

PRIMAL

Halozyme Therapeutics

Phase 1 Terminated

16 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡